DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Gianni L, Pienkowski T, Im YH. et al.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncol 2012;
13 (01) 25-32
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.